Why Monthly Costs Matter for Long-Term Weight Management Success
Wegovy vs Ozempic vs Mounjaro: Legal Licensing and Monthly Cost Reality
When comparing Wegovy vs Ozempic vs Mounjaro monthly costs in the UK, it's essential to understand that only Wegovy and Mounjaro are legally licensed for weight management. Ozempic, whilst containing the same active ingredient as Wegovy (semaglutide), is licensed exclusively for type 2 diabetes treatment. Promoting Wegovy for weight management constitutes illegal off-label advertising under UK regulations. This fundamental distinction affects both availability and legal compliance when sourcing these treatments.
Wegovy operates as a GLP-1 receptor agonist, while Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 agonist. Both treatments require prescription-only medicine status and must be prescribed alongside a reduced-calorie diet and increased physical activity. The monthly cost structure differs significantly between these options, with Wegovy's transparent dose escalation providing predictable budgeting from £79.99 in month one to £209.99 at maintenance dose.
Monthly Pricing Breakdown: Wegovy vs Ozempic vs Mounjaro Cost Analysis
Understanding the Wegovy vs Ozempic vs Mounjaro pricing landscape requires examining the complete 16-week escalation period and ongoing maintenance costs. Wegovy begins at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and finally £209.99 for the 2.4mg maintenance dose from week 17 onwards. These prices reflect the final cost after applying discount codes FIRST40 for new customers or DOSE25 for returning patients at checkout.
Annual maintenance cost calculations show approximately £2,519.88 for continuous 2.4mg Wegovy supply (12 months × £209.99). Our bundle options, such as the Ultimate Stability Trio providing three 2.4mg pens for £649.99, offer convenience benefits including fewer orders, Reliable Supply continuity, and single cold-chain delivery. The escalation phase totals £524.96 across 16 weeks, making the first-year investment approximately £3,044.84 including dose titration and nine months of maintenance therapy.
Clinical Evidence: Wegovy vs Ozempic vs Mounjaro Trial Outcomes
Clinical evidence supporting Wegovy comes primarily from the STEP trial programme, with Wilding et al., NEJM, 2021, demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo. The STEP 5 trial showed sustained 15.2% weight reduction at two years, whilst SELECT trial data revealed a 20% reduction in major cardiovascular events. These outcomes occurred alongside reduced-calorie diet and increased physical activity interventions.
Mounjaro's clinical profile differs due to its dual GIP and GLP-1 mechanism, though direct head-to-head comparisons between Wegovy vs Ozempic vs Mounjaro trials aren't appropriate given different study designs, populations, and endpoints. Both treatments require individual clinical assessment to determine suitability, with prescribers evaluating BMI criteria, comorbidities, and patient-specific factors during the consultation process.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate appetite and blood sugar levels. The medication works on brain appetite centres, particularly the hypothalamus, to reduce hunger signals and promote satiety after smaller meals. This mechanism may help reduce food cravings and overall caloric intake when combined with lifestyle modifications. The once-weekly injection schedule provides sustained hormone level maintenance, supporting consistent appetite regulation throughout the treatment period. Unlike rapid-acting appetite suppressants, Wegovy's gradual dose escalation allows the body to adapt to treatment effects whilst minimising potential side effects during the initial titration phase.
Ordering Process: From Assessment to Monthly Delivery
EverydayMeds streamlines the Wegovy vs Ozempic vs Mounjaro comparison process through our comprehensive three-minute online clinical assessment, covering medical history, current medications, weight management goals, and eligibility criteria. Following submission, our qualified prescribers review applications within three working days (or 24 hours with express service), ensuring thorough evaluation against MHRA licensing criteria and NICE TA875 guidelines. Once approved, we dispatch medications via next-day delivery using specialised cold-chain transportation maintaining the required 2-8°C temperature range. Our GPhC-registered pharmacy (#9012878) maintains rigorous quality standards throughout the supply chain, from pharmaceutical-grade storage facilities to temperature-controlled delivery partnerships. Monthly repeat orders can be scheduled in advance, ensuring continuous treatment availability without interruption to your weight management programme.
Storage and Practical Considerations: Wegovy vs Mounjaro Advantages
Wegovy offers superior storage flexibility compared to Mounjaro, maintaining stability for up to six weeks at room temperature (below 30°C) once removed from refrigeration, versus Mounjaro's 21-day room temperature limit. This advantage proves particularly valuable for travel, work situations, or temporary refrigeration issues. The FlexTouch pen delivery system provides precise dosing with clear dose selection and injection completion confirmation. Mandatory dose escalation follows a specific 16-week schedule that cannot be accelerated, ensuring optimal tolerance and efficacy development. Each pen contains four weekly doses, with clear labelling indicating the specific strength and detailed patient information leaflets provided with every order.
Budgeting Strategies: Managing Wegovy vs Ozempic vs Mounjaro Monthly Costs
Effective budgeting for Wegovy vs Ozempic vs Mounjaro treatments requires planning beyond initial monthly costs, considering the long-term nature of weight management therapy. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide cost-effective coverage for the first two months whilst reducing order frequency. The Consistency bundle range offers doubled monthly supplies at advantageous pricing, with the Consistency 2.4mg bundle providing two maintenance pens for £419.99.
Financial planning should account for potential treatment duration, as STEP trial data indicates weight regain of approximately two-thirds within one year of discontinuation. Many patients benefit from exploring our Take-It-Slow bundles, designed for extended titration periods, allowing gradual adaptation to treatment effects. The Gentle Start Trio provides extended 0.25mg dosing followed by 0.5mg transition, supporting patients who require longer adaptation periods during initial treatment phases.
Making Your Decision: Wegovy vs Ozempic vs Mounjaro Selection Factors
Choosing between Wegovy vs Ozempic vs Mounjaro ultimately depends on individual clinical factors, legal licensing status, and personal treatment preferences. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your specific medical profile and weight management goals. Consider factors including injection frequency preferences, storage requirements, mechanism of action, and long-term cost implications when discussing options with healthcare providers. Our clinical team provides ongoing support throughout your treatment journey, from initial assessment through dose escalation and maintenance phases. Whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-agonist mechanism, EverydayMeds ensures consistent access to licensed treatments with transparent pricing and professional clinical oversight. Start your assessment today using discount code FIRST40 for new customers, and experience the difference that proper clinical support makes in your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
